U.S. Biotech Stock News

Trump Media & Technology Group (NasdaqGM:DJT) has outlined a pivot toward Bitcoin treasury management as a primary business activity. The company plans to expand its financial assets, introduce bitcoin linked options, and pursue new ventures tied to ETFs and prediction markets. Management has also flagged initiatives in AI powered search and a potential merger related to fusion energy as part of a broader shift beyond the Truth Social platform. For investors following Trump Media &...

Recently, Western Midstream Partners restructured its long-term agreement with Occidental into a fixed-fee contract with minimum volume commitments through 2035, with Occidental also returning shares worth about US$610 million, while expanding agreements with ConocoPhillips and growing its produced water operations. This combination of long-duration fee-based contracts, asset-light water infrastructure expansion, and a significant equity giveback from Occidental could reshape Western...

Why Visteon Stock Is Drawing Fresh Attention Visteon (VC) is back on many investors’ radars after a period of mixed share performance, with the stock showing a 9.4% total return over the past year but weaker recent momentum. At a last close of US$90.67, Visteon sits against a backdrop of annual revenue of US$3.8b and net income of US$201 million, giving investors concrete numbers to weigh against recent volatility. See our latest analysis for Visteon. Recent trading has been softer, with a 30...

If you are wondering whether L3Harris Technologies is priced fairly after its recent run, this article will help you make sense of where the stock sits on the value spectrum. The share price recently closed at US$364.26, with returns of 3.9% over 30 days and 19.6% year to date, while the 1 year return stands at 77.3% and the 5 year figure at 109.6%. Recent news around L3Harris has focused on its role in defense and aerospace, with investors watching how contract activity and sector sentiment...

On March 9, 2026, Archer-Daniels-Midland expanded its Board to 13 members by appointing former LyondellBasell CFO Michael McMurray, who will serve on the Audit and Sustainability and Technology committees. By adding a director with extensive financial and industrial experience, ADM is signaling a reinforced focus on governance, risk oversight, and long-term sustainability priorities. We’ll now examine how McMurray’s appointment to ADM’s Board could influence the company’s investment...

Structure Therapeutics (GPCR) reported fourth quarter net income of US$33 million, compared with a net loss of US$36.48 million a year earlier, marking a clear shift in its recent financial results. See our latest analysis for Structure Therapeutics. Despite the shift to quarterly net income, Structure Therapeutics’ recent share price return has softened, with a 30 day share price return of 26.26% and a year to date share price return of 14.56%. By contrast, the 1 year total shareholder...

Why Madrigal Pharmaceuticals Is On Investors’ Radar Madrigal Pharmaceuticals (MDGL) has attracted fresh attention after recent market moves, with the share price near US$431.53 and returns showing mixed results over the past year and past 3 months. For investors tracking performance, the stock shows a 1 day return of about a 0.3% decline and a 7 day return of roughly a 0.8% decline, while the past month and past 3 months reflect deeper pullbacks. See our latest analysis for Madrigal...

Chevron has relocated its headquarters from California to Houston, citing the regulatory and litigation environment in California. The company is pursuing new oil extraction agreements in Venezuela following recent political changes backed by the US. Chevron's Middle East operations are affected as oil flows through the Strait of Hormuz fall to about 3% of normal levels and Gulf production is disrupted by conflict. For investors watching NYSE:CVX, this cluster of developments goes beyond...

If you are wondering whether Chubb's current share price reflects its true worth, you are not alone. Many investors are asking if the recent price level still offers value. Chubb shares last closed at US$322.76, with returns of 4.1% year to date and 15.2% over the past year, while the stock shows a 3.4% decline over 7 days and a 1.0% decline over 30 days that may have caught your eye. Recent headlines around Chubb have focused on its position in the insurance space and how investors are...

Wondering if Exelon at around US$48.84 is giving you fair value right now, or if the market is missing something important about this utility giant. The stock has been relatively steady over the past week with a 0.8% decline, while its 30 day return of 11.1% and 1 year return of 18.7% may catch the eye of investors who are thinking about growth potential or shifting risk perceptions. Those moves sit against a wider backdrop of ongoing interest in regulated utilities. In this area, investors...

In early March 2026, Hewlett Packard Enterprise reported past first-quarter results showing higher sales of US$8,425 million, raised its full-year 2026 earnings guidance, continued an extensive multi-year share buyback now totaling about US$12.86 billion, and affirmed a regular dividend of US$0.1425 per share. A key insight is that networking has become a central earnings engine, helping drive record per-share profits and stronger guidance, while the company simultaneously returns large...

If you are wondering whether Ralph Lauren's share price still offers value after a strong run, this article will walk through what the current market price might be implying about the business. The stock last closed at US$338.95. While the share price shows a 5.8% decline over 7 days and a 2.6% decline over 30 days, it also shows a 6.5% decline year to date, a 52.4% gain over 1 year, and more than 3x over 3 years. Recent coverage around Ralph Lauren has focused on its brand strength, product...

Perimeter Solutions, Inc. reported past fourth-quarter 2025 sales of US$102.75 million, up from US$86.23 million a year earlier, but swung to a net loss of US$140.23 million and a basic loss per share of US$0.94 from prior-year earnings. For 2025 as a whole, the company increased sales to US$652.86 million while recording a much larger net loss of US$206.37 million, against the backdrop of its role as the sole aerial fire-retardant supplier under a new five-year U.S. Department of...

Gallagher (NYSE:AJG) released its 2026 Employee Communications Report highlighting a widespread lack of structured change management communication strategies. The report finds internal communications teams are increasingly overwhelmed, raising risks around leadership trust and employee burnout. The findings point to an emerging organizational risk that has attracted limited attention compared with topics like deals or quarterly earnings. For investors looking at Gallagher (NYSE:AJG), this...

America First Refining has broken ground on what is described as the first major US refinery project in nearly 50 years. The project highlights renewed attention on domestic refining capacity and long term US energy independence goals. Marathon Petroleum (NYSE:MPC), the largest US refiner by capacity, sits at the center of these shifts given its scale and link to American shale oil. For you as an investor, this new refinery project puts a fresh spotlight on the core business of Marathon...

Pratt & Whitney, an RTX (NYSE:RTX) business, received a follow on contract to supply TJ150 turbojet engines for Leidos Dynetics' AGM-190A small cruise missile program. The contract expands RTX's role in next generation autonomous weapon systems and highlights the use of additive manufacturing in engine development. For you as an RTX watcher, this contract sits in the core of the company’s defense profile, where Pratt & Whitney focuses on propulsion for military platforms. Interest in...

Why ERAS-0015 is at the center of the story Erasca (ERAS) has just exercised its option to secure worldwide rights to its pan RAS molecular glue ERAS-0015 by expanding its license with Joyo Pharmatech to cover China, Hong Kong, and Macau. This follows a recent clinical trial collaboration with Tango Therapeutics involving ERAS-0015 and increased analyst attention tied to upcoming Phase 1 data, which helps explain why the stock is attracting more investor focus. See our latest analysis for...

FTAI Aviation (FTAI) is back on traders’ radar after a Q4 2025 earnings miss was followed by a 6.14% share price jump, upbeat 2026 guidance, and fresh leadership appointments in key finance roles. See our latest analysis for FTAI Aviation. That Q4 earnings miss and the leadership reshuffle come after a strong run, with a 90 day share price return of 42.71% and a very large 3 year total shareholder return. The recent 7 day pullback of 8.13% looks more like a pause than a change in...

C3.ai (AI) is back in focus after quarterly results showing a 46% year on year revenue drop, weaker guidance for the year ahead, and a restructuring plan featuring layoffs and cost cuts. See our latest analysis for C3.ai. Those weak quarterly numbers and the restructuring plan help explain why C3.ai’s 30 day share price return is 20.45% lower and its 1 year total shareholder return is 57.17% lower. This signals fading momentum despite new product launches and an upcoming conference...

FactSet Research Systems overview after recent price moves FactSet Research Systems (FDS) has drawn attention after a recent pullback, with the stock down about 3% over the past day and 8.8% over the past week, while its past month return is slightly positive. Over the past 3 months, the share price shows a 29.5% decline and the 1 year total return is down about 51.5%. This has prompted some investors to reassess how current pricing lines up with FactSet’s fundamentals and value score. See...

In recent weeks, United States Antimony Corporation has secured a US$27 million Department of War award for domestic critical mineral extraction and processing, while management has promoted this and an initial resource report on the Fostung Tungsten property on major business media and at multiple Toronto conferences. These developments underscore how government-backed funding and an estimated US$4.60 billions gross revenue opportunity at Fostung could reshape the company’s role in North...

Jefferies has initiated coverage on Life Time Group Holdings (LTH), highlighting the company’s position as a premium fitness brand. This new Wall Street attention is putting the stock on more investor watchlists. See our latest analysis for Life Time Group Holdings. Life Time Group Holdings’ share price has pulled back over the past month, with a 30 day share price return of a 10.18% decline. However, the 3 year total shareholder return of 62.84% points to a much stronger longer term picture,...

If you are wondering whether Alliant Energy's current share price still offers value or if most of the opportunity is already priced in, this article walks through the key pieces you need to consider. The stock last closed at US$70.81, with returns of 5.8% over 30 days, 8.0% year to date, 17.5% over 1 year, 47.7% over 3 years, and 61.0% over 5 years. This performance may have shifted how investors think about its risk and return profile. Recent coverage of Alliant Energy has focused on its...

Geron (GERN) has put fresh equity financing in focus after announcing a US$150 million at the market follow on common stock offering, alongside a new universal shelf registration covering multiple security types. See our latest analysis for Geron. At a share price of US$1.66, Geron has seen a 19.42% 90 day share price return and a 25.76% year to date share price return. However, its 1 year total shareholder return of a 6.21% decline points to building short term momentum against a weaker...